ATE46444T1 - Rektale verabreichung von arzneimitteln mit hilfsmitteln. - Google Patents

Rektale verabreichung von arzneimitteln mit hilfsmitteln.

Info

Publication number
ATE46444T1
ATE46444T1 AT82111671T AT82111671T ATE46444T1 AT E46444 T1 ATE46444 T1 AT E46444T1 AT 82111671 T AT82111671 T AT 82111671T AT 82111671 T AT82111671 T AT 82111671T AT E46444 T1 ATE46444 T1 AT E46444T1
Authority
AT
Austria
Prior art keywords
drug
drugs
drug form
rectal administration
enhancing
Prior art date
Application number
AT82111671T
Other languages
English (en)
Inventor
Jose Alexander
Joseph A Fix
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE46444T1 publication Critical patent/ATE46444T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AT82111671T 1981-12-30 1982-12-16 Rektale verabreichung von arzneimitteln mit hilfsmitteln. ATE46444T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/335,498 US4425337A (en) 1981-12-30 1981-12-30 Adjuvants for rectal delivery of drug
EP82111671A EP0083032B1 (de) 1981-12-30 1982-12-16 Rektale Verabreichung von Arzneimitteln mit Hilfsmitteln

Publications (1)

Publication Number Publication Date
ATE46444T1 true ATE46444T1 (de) 1989-10-15

Family

ID=23312038

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82111671T ATE46444T1 (de) 1981-12-30 1982-12-16 Rektale verabreichung von arzneimitteln mit hilfsmitteln.

Country Status (7)

Country Link
US (1) US4425337A (de)
EP (1) EP0083032B1 (de)
JP (1) JPS58118510A (de)
AT (1) ATE46444T1 (de)
DE (1) DE3279946D1 (de)
GR (1) GR78416B (de)
IE (1) IE55326B1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413915D0 (en) * 1984-05-31 1984-07-04 Wellcome Found Phenothiazine compounds
GB8426152D0 (en) * 1984-10-16 1984-11-21 Reckitt & Colmann Prod Ltd Medicinal compositions
US4729989A (en) * 1985-06-28 1988-03-08 Merck & Co., Inc. Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts
US4822773A (en) * 1985-06-28 1989-04-18 Merck & Co., Inc. Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts
US4692441A (en) * 1985-08-16 1987-09-08 Merck & Co., Inc. Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities
US5344656A (en) * 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US5508038A (en) * 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
EP2758403B1 (de) 2011-09-21 2016-04-27 Inception Orion, Inc. Tricyclische verbindungen als neurogene wirkstoffe und neuroprotektiva
BR112015014178A2 (pt) 2012-12-17 2017-07-11 Parion Sciences Inc compostos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil)carbamimidoil) pirazina-2- carboxamida
PT2931713T (pt) 2012-12-17 2017-02-22 Parion Sciences Inc Derivados de cloro-pirazina carboxamida úteis para o tratamento de doenças favorecidas por insuficiente hidratação das mucosas
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2872376A (en) * 1956-09-21 1959-02-03 Warner Lambert Pharmaceutical Ataractic composition comprising 10-(1-methyl-3-piperidylmethyl)-phenothia-zine and 10-(3-dimethyl-amino-propyl)-2-chlorophenothiazine
GB1224883A (en) * 1967-07-25 1971-03-10 Aspro Nicholas Ltd Improvements in or relating to hypnotic compositions
US3689646A (en) 1969-09-04 1972-09-05 Univ Pennsylvania Antimutagenic treatment of bacteria
AU541247B2 (en) * 1979-12-20 1985-01-03 R.P. Scherer Corporation Adjuvants for rectal delivery of drug substances

Also Published As

Publication number Publication date
EP0083032A3 (en) 1984-09-05
IE55326B1 (en) 1990-08-15
GR78416B (de) 1984-09-27
EP0083032A2 (de) 1983-07-06
IE823063L (en) 1983-06-30
EP0083032B1 (de) 1989-09-20
US4425337A (en) 1984-01-10
DE3279946D1 (en) 1989-10-26
JPS58118510A (ja) 1983-07-14

Similar Documents

Publication Publication Date Title
ATE46444T1 (de) Rektale verabreichung von arzneimitteln mit hilfsmitteln.
NO920740D0 (no) Doseringsform for oral administrering av hypoglykemisk glipizid
ATE96308T1 (de) Dosierform fuer verabreichung in der humanmedizin.
ES513357A0 (es) "un sistema terapeutico bajo la forma de un vendaje para administrar el medicamento".
DK0527835T3 (da) Doseringsform til afgivelse af et anti-Parkinsonmiddel
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
DK349889D0 (da) Anvendelse af polyacrylater til fremstilling af et laegemiddel
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
ES275173Y (es) Una disposicion de punta de dosificacion para administrar una dosis de medicamento, alimentos, vitaminas o similares a un paciente.
AU541247B2 (en) Adjuvants for rectal delivery of drug substances
JPS56138111A (en) Suppository containing unsaturated fatty acid or salt thereof
JPS56138110A (en) Suppository containing citric acid or salt thereof
JPS56138112A (en) Suppository containing ascorbic acid or sodium ascorbate
SU449724A1 (ru) Отхаркивающее средство "мукалтин'
RU94006631A (ru) Способ лечения неспецифического язвенного колита
RU94006632A (ru) Способ лечения неспецифического язвенного колита
ES171385U (es) Vendaje medico.
ES277845Y (es) Una disposicion de punta de dosificacion para administrar una dosis de medicamento, alimentos, vitaminas o similares, a un paciente
GB1149313A (en) Improvements relating to therapeutically active hydroxychloroquine salts
ES1008953Y (es) Un dispositivo para la reconstitucion y administracion de sustancias terapeuticas a pacientes mediante infusion.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee